According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.06000. In 2022 the company made an earnings per share (EPS) of -$0.08000 an increase over its 2021 EPS that were of -$0.15.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.06000 | -25% |
2022 | -$0.08000 | -46.67% |
2021 | -$0.15 | -11.76% |
2020 | -$0.17 | -15% |
2019 | -$0.20 | 5.26% |
2018 | -$0.19 | -26.92% |
2017 | -$0.26 | -7.14% |
2016 | -$0.28 | -40.43% |
2015 | -$0.47 | 291.67% |
2014 | -$0.12 | -7.69% |
2013 | -$0.13 | -43.48% |
2012 | -$0.23 | -25.81% |
2011 | -$0.31 | 55% |
2010 | -$0.20 | 25% |
2009 | -$0.16 | 0.08% |
2008 | -$0.16 | -11.12% |
2007 | -$0.18 | -0.16% |
2006 | -$0.18 | 28.59% |
2005 | -$0.14 | -12.49% |
2004 | -$0.16 | -16.05% |
2003 | -$0.19 | 19.07% |
2002 | -$0.16 | 14.45% |
2001 | -$0.14 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -23,575.50% | ๐บ๐ธ USA |
Pfizer PFE | $1.86 | -3,200.00% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -5,053.67% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | -9,148.82% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $6.76 | -11,366.67% | ๐บ๐ธ USA |